Biogen Inc. buy UBS Group AG
Start price
22.04.26
/
50%
€162.56
Target price
22.04.27
€191.59
Performance (%)
-1.03%
Price
23.04.26
€160.88
Summary
This prediction is currently active. With a performance of -1.03%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. This prediction currently runs until 22.04.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Biogen Inc. | -1.03% |
| iShares Core DAX® | 0.411% |
| iShares Nasdaq 100 | 3.678% |
| iShares Nikkei 225® | 2.701% |
| iShares S&P 500 | 2.445% |
Comments by UBS_Group_AG for this prediction
In the thread Biogen Inc. diskutieren
Biogen (BIIB) was upgraded by UBS Group AG from "neutral" to "buy". They now have a $225.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat